Clinical and Translational Science Award (CTSA) UM1 at Columbia University
NCATS - National Center for Advancing Translational Sciences
About This Grant
Project Summary Our Clinical and Translational Science Award (CTSA) hub is situated in Upper Manhattan at the Irving Institute for Clinical and Translational Research (Irving Institute) of Columbia University (CU), based at the CU Irving Medical Center (CUIMC). Our evolution as institutional leaders and maturation as a comprehensive CTSA hub enables us to drive innovative clinical and translational science (CTS) and clinical and translational research (CTR), in collaboration with our hospital partner NewYork-Presbyterian. The mission of our hub is to improve the health and wellbeing of patients and communities through our strategic vision and goals to catalyze all phases of CTS and CTR to achieve a fully integrated research environment locally and across the CTSA Program. We now prioritize systematic and deep engagement with all our stakeholders to achieve the greatest impact on research and health through CTS and CTR. Programs and services will be deployed through user-friendly research navigation and optimization using dissemination and implementation science (IS) to inform our cyclical approach to identify, develop, demonstrate, and disseminate (ID3) innovations that address CTR gaps and opportunities. Our record of innovation permeates our education, services, and research and guides our evaluation and continuous quality improvement strategy. CTS innovations are proposed for near-peer mentoring, digital health in communities, data and design, cell therapeutics, research core utilization, health system- embedded trials, federated learning, artificial intelligence (AI) and return of research results to participants. Irving Institute leaders are integrated into CUIMC governance to successfully implement our vision and goals. Module B Strategic Management approach and infrastructure will be optimized to catalyze CTS innovations. The ID3 approach, enhanced by tailored engagement and IS, will integrate institutional and community priorities, stimulate CTS innovations across the T0–T4 spectrum, and broadly disseminate services and programs with greatest potential to address major CTR gaps. Through personalized training, Module C1 will create and expand models to train a skilled, interdisciplinary workforce to advance rigorous CTR and CTS and enhance participation of the workforce and communities in CTR. Module C2 will deploy bidirectional engagement with our community ambassadors, patients, and local communities to develop and disseminate programs that address community priorities to improve health. Modules D1 and D3 will use research navigation and optimization to develop and cyclically refine research-friendly service programs as well as innovations in AI, informatics, precision medicine, and federated learning to accelerate CTR and CTS. Through our Module D2 Pilots and Element E CTS Program, we will work directly with stakeholders to tackle major CTS challenges, such as a system for return of individual results to research participants as well as opportunities in cell therapy, -omic core utilization in CTR, and AI in research, operations and health. Through these innovations, our hub will drive research efficiency, quality, and impact and align with CTSA Program goals to deliver more treatments to more patients more quickly.
Grant Summary
Clinical and Translational Science Award (CTSA) UM1 at Columbia University is a NCATS - National Center for Advancing Translational Sciences grant providing up to $10.7M for university, nonprofit, healthcare org. Applications are due 2033-05-31 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $10.7M
2033-05-31
- 1Confirm your organization is eligible for Clinical and Translational Science Award (CTSA) UM1 at Columbia University from NCATS - National Center for Advancing Translational Sciences, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NCATS - National Center for Advancing Translational Sciences before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NCATS - National Center for Advancing Translational Sciences's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Clinical and Translational Science Award (CTSA) UM1 at Columbia University: Frequently Asked Questions
Who is eligible for the Clinical and Translational Science Award (CTSA) UM1 at Columbia University?
Clinical and Translational Science Award (CTSA) UM1 at Columbia University is offered by NCATS - National Center for Advancing Translational Sciences and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Clinical and Translational Science Award (CTSA) UM1 at Columbia University provide?
Clinical and Translational Science Award (CTSA) UM1 at Columbia University provides up to $10.7M per award from NCATS - National Center for Advancing Translational Sciences. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Clinical and Translational Science Award (CTSA) UM1 at Columbia University deadline?
Applications for Clinical and Translational Science Award (CTSA) UM1 at Columbia University are due 2033-05-31 (open). Because deadlines can change, verify the date with the funder, NCATS - National Center for Advancing Translational Sciences, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Clinical and Translational Science Award (CTSA) UM1 at Columbia University?
To apply for Clinical and Translational Science Award (CTSA) UM1 at Columbia University, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NCATS - National Center for Advancing Translational Sciences.